Quarterly report pursuant to Section 13 or 15(d)

8. Share-Based Compensation (Details Narrative)

v3.5.0.2
8. Share-Based Compensation (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Share based compensation $ 616,933 $ 2,057,519 $ 2,635,196 $ 2,294,717  
Warrants outstanding 758,347   758,347   758,347
Fair value adjustment of warrants $ (1,790) 326,123 $ 1,116,852 $ 418,826  
Employee Stock Options [Member]          
Options granted     12,122 12,122  
Share based compensation 521,746 1,412,992 $ 1,311,074 $ 1,497,295  
Incremental compensation expense from exercise extension date     $ 24,000    
Non Employee Stock Options [Member]          
Options granted     0 0  
Share based compensation $ 60,435 $ 177,351 $ 62,938 $ 186,544  
Options exercised     0 0  
Common Stock Awards [Member]          
Common stock grants 8,146 371,292 20,309 605,580  
Share based compensation $ 36,542 $ 116,045 $ 144,332 $ 167,045  
Warrants [Member] | Serum Institute of India Ltd [Member]          
Fair value adjustment of warrants     $ 1,370,000    
Warrants issued     212,122